LMU Klinikum München

PostDoc in Precision Immunotherapy / Antibody Engineering (m/w/d)

LMU Klinikum München

 München, Bavaria, Germany

Campus Innenstadt

Working hours

Full time

Institution

Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital

Department

Research - Klein Lab at the CCRC & Gene Center LMU

Date of entry

At the earliest possible date

Application deadline

Swift

Reference Number

2026-K-0416

The Hospital of the University of Munich, Germany, is one of the largest and most competitive university hospitals in Germany and Europe. 48 specialized hospitals, departments and institutions harbouring excellent research and education provide patient care at the highest medical level with around 12.000 employees.

Scope of duties

As a PostDoc in the research group of Prof. Christoph Klein, you will join a translational research program and with the option to take on a leadership role.

You will be involved in a precision immunotherapy program based on an innovative conditional strategy (“AND-GATE”) to target cancer and immune cells. This includes the engineering, production and purification of novel recombinant antibody formats, the setup and optimization of in vitro and in vivo functional assays, and the further development of our iPSC-derived organoid system for patient-specific therapy testing.

You will help plan and coordinate ongoing experiments, prepare scientific data for publication and grant applications, and support the scientific supervision of junior researchers.

Our requirements

  • Completed PhD in Biology, Biochemistry, Biotechnology or a comparable field
  • Solid experience in the following areas:
  • Antibody engineering, protein expression and purification (e.g., FPLC)
  • Molecular biology and cell biology techniques
  • iPSC cultivation and/or differentiation into immune cell types
  • Experience with in vitro or in vivo functional assays and multi-omics data analysis is an advantage
  • The ability to work independently, as well as in an interdisciplinary and international team
  • A structured, meticulous and solution-oriented working style
  • Excellent English skills; German skills are an advantage

Our offer

  • The position is initially funded for two years . Subject to a positive scientific re-evaluation, an extension is possible
  • An innovative and challenging position within the research group of Prof. Christoph Klein, operating at the interface of translational immunotherapy, stem cell biology and precision medicine.
  • An international and interdisciplinary research environment, supported by close collaboration with academic and industrial partners within an established research network
  • Close collaboration with basic scientists, bioinformaticians and clinician scientists on two complementary translational projects
  • A collaborative, supportive and inspiring working environment that encourages scientific independence
  • Employment according to the German public-sector collective agreement (TV-L), including annual leave and additional benefits in accordance with the applicable regulations

Offers and services of the employer

Further education and training

Job ticket

Company pension scheme

Discounts

Childcare services

Staff accommodation (if available)

Mobile work (if suitable)

Mr. Dr. Nickels, Philipp

+49 89 4400 57109

Application format

Please use the Online-Form for your application

Disabled persons will be preferentially considered in case of equal qualification. Presentation costs cannot be refunded.

Please note that we cannot reimburse travel expenses incurred through interviews.

We ask you for your understanding that postal applications will not be returned, but will be destroyed in accordance with data protection regulations. The data usage information also applies to postal applications

Apply now

Job details

Location
 München, Bavaria, Germany
Job category
Research and Development
Employment type
Full-time
Experience level
Experienced
Therapy platform
Stem Cells
Minimum education
PhD
Posted
Nov 6, 2026
Closing date
Jan 5, 2027

Actions

Request removal of this listing